An interstitial fluid transdermal extraction system for continuous glucose monitoring by Li, D et al.
Title An interstitial fluid transdermal extraction system for continuousglucose monitoring
Author(s) Yu, H; Li, D; Roberts, RC; Xu, K; Tien, NC
Citation Journal Of Microelectromechanical Systems, 2012, v. 21 n. 4, p.917-925
Issued Date 2012
URL http://hdl.handle.net/10722/175546
Rights IEEE Journal of Microelectromechanical Systems. Copyright ©IEEE
JOURNAL OF MICROELECTROMECHANICAL SYSTEMS, VOL. 21, NO. 4, AUGUST 2012 917
An Interstitial Fluid Transdermal Extraction System
for Continuous Glucose Monitoring
Haixia Yu, Dachao Li, Robert C. Roberts, Kexin Xu, and Norman C. Tien
Abstract—A novel microfluidic system which is fabricated with
five polydimethylsiloxane layers for interstitial fluid (ISF) ex-
traction, collection, and measurement toward the application of
continuous and real-time glucose monitoring is presented in this
paper. The system consists of a micro vacuum generator for ISF
transdermal extraction and fluid manipulation, micro chambers
for the collection of ISF, micro pneumatic valves for fluid manage-
ment, and a micro flow sensor for ISF volume measurement. Se-
quentially controlled by the pneumatic valves, the ISF extraction,
collection, and volumetric measurement functions of the system
were demonstrated using the stable vacuum generated by the
integrated vacuum generator. Through low-frequency ultrasound
pretreated full-thickness pig skin, the normal saline solution with
different glucose concentrations was transdermally extracted, col-
lected, and measured. The absolute error in the volume measure-
ment of the transdermally extracted “ISF analog” was less than
0.05 μL. The microfluidic system makes it possible to realize the
clinical application of continuous glucose monitoring based on ISF
transdermal extraction technology. [2011-0329]
Index Terms—Continuous glucose monitoring, interstitial fluid
(ISF), microfluidic system, transdermal extraction.
I. INTRODUCTION
D IABETES IS a pandemic forcing millions of people tomeasure their blood glucose levels daily. Conventional
self-testing methods require a drop of blood in the range
of 0.3–10.0 μL[1] for each glucose measurement, a painful
and inconvenient procedure with poor patient compliance. In
addition, effective diabetes control requires frequent and ac-
curate glucose monitoring. Consequently, there has been, and
continues to be, considerable investments in the development of
continuous glucose monitoring technologies [2]–[7]. A variety
of techniques are being examined, including optical sensors
[8], the physical implantation of devices to measure glucose
directly in a local subcutaneous environment, and the minimally
invasive glucose monitoring methods which test the glucose
level using transdermally extracted interstitial fluid (ISF) [9].
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Although monitoring glucose levels using optical techniques
is truly noninvasive, an affordable, efficient, and portable op-
tical system is not in the immediate future. Subcutaneously
implanted glucose sensors are commercially available from
DexCom [10], Medtronic [11], and Abbott Laboratories [12].
However, the implantation of these sensors is invasive, and
these sensors require frequent calibration to mitigate instabil-
ities over time, making long-term operation difficult [13].
Contrary to the previously mentioned techniques, transder-
mal extraction of ISF offers an attractive method of minimally
invasive blood glucose monitoring. In this method, a sample
of ISF is transdermally extracted and subsequently analyzed
for glucose concentration. Good correlation between the glu-
cose concentration of the extracted ISF and the blood glucose
concentration was reported [3], [14]. However, this approach is
limited by the low permeability of the human skin to glucose
due to the outermost stratum corneum (SC) layer. A variety
of approaches have been suggested to enhance the transdermal
transport of molecules [15]. These include the use of chemicals
to modify the skin structure [16], the application of electric
fields [17], and the application of ultrasound [18]. After the
skin permeability is increased by ultrasound pretreatment, the
elevated skin permeability can persist for at least 42 h under
occlusion [19], and ISF can be transdermally extracted with
higher fluxes as vacuum is applied to enhance the convection
of ISF [3]. High fluxes of analytes are beneficial by having
high detectable analyte concentrations and short collection
times, by requiring a smaller skin area for sampling, and by
lowering interference from background analytes (i.e., sweat)
[14]. Although the transdermal ISF extraction technique using
ultrasound and vacuum offers the promise of noninvasive, con-
tinuous, and real-time glucose monitoring, this technique only
extracts a minute volume of ISF, which scatters on the skin sur-
face, making it unsuitable for ISF collection and measurement
by using macroscale systems. In order to collect the minute vol-
ume of ISF, a certain volume of normal saline, which is similar
to the ISF, is required to mix with the transdermally extracted
ISF and form a manipulable volume of fluid for easy collection.
In addition, due to the variation of skin permeability with time
[20], the volumes of transdermally extracted ISF will also vary.
As a result, the glucose concentration of the collected fluid is
not only affected by the glucose concentration of ISF, but also
by the volume ratio between the transdermally extracted ISF
and the normal saline solution used to help collect ISF. There-
fore, it is critical to make precise ISF volume measurements in
order to calculate blood glucose concentrations accurately.
In this paper, a novel integrated microfluidic system ca-
pable of automatic extraction, collection, and volumetric
1057-7157/$31.00 © 2012 IEEE
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Fig. 1. Schematic view of the system. EC: Extraction Chamber, CC: Collection Chamber, V: Vacuum, GS: Glucose Sensor, VG: Vacuum Generator, NSC:
Normal Saline Chamber.
TABLE I
VALVE SEQUENCING WORKFLOW
measurement of the ISF is developed. This device overcomes
the fluid handling hurdles that are crucial for a low-cost and
portable ISF-based glucose monitoring system.
II. STRUCTURE DESIGN
A. System Overview
The schematic view of a microfluidic continuous glucose
monitoring device which can be worn similarly to a watch is
shown in Fig. 1(a). The device monitors blood glucose level
based on the measurement of transdermally extracted ISF. It
consists of a microfluidic system for ISF transdermal extraction,
collection, and volumetric measurement, which is present in
this paper, and a micro glucose sensor which is under devel-
opment. As shown in Fig. 1(b), the microfluidic system is com-
posed of a vacuum generator, pneumatic valves, a flow sensor,
fluid chambers, and interconnecting microfluidic channels.
The vacuum generator is used to provide the driving force for
both ISF extraction and fluid manipulation during normal saline
injection and ISF collection processes. The pneumatic valves
are computer programmed to sequentially control the ISF ex-
traction, collection, and volumetric measurement processes (re-
fer to Table I). The flow sensor, which monitors the electrolytic
fluid flowing between the chambers, is integrated into the mi-
crofluidic channel to enable accurate volumetric measurement
of the extracted ISF. Finally, the fluid chambers are used for the
introduction of normal saline solution and the extraction and
collection of ISF.
During the ISF extraction, collection, and volumetric mea-
surement processes, the vacuum generator first provides a stable
vacuum to prepare for the subsequent actions. Next, a defined
volume of normal saline, which is stored in the normal saline
chamber, is injected into the extraction chamber to help collect
the scattered ISF. During actual operation, the extraction cham-
ber is sealed to the skin [as shown in Fig. 1(a)], enabling the
system to harvest ISF. Vacuum is then applied to the extraction
chamber for ISF extraction, and as the ISF is retrieved, it mixes
with the normal saline to form a manipulable volume of fluid.
After extraction, the fluid volume is measured as it transfers
from the extraction chamber to the collection chamber where a
glucose sensor will ultimately reside. Calculating the volume
difference between the initial defined volume and the post
extraction measured volume yields the amount of extracted ISF,
which is the key to obtaining accurate glucose monitoring.
B. Structure Design of the Micro Vacuum Generator
In order to establish a miniaturized and integrated system, a
compact vacuum generator is required for this application. The
Venturi tube, which is simple in design and can be fabricated
on a single mask layer, is selected as the core component of
the vacuum generator for the application of transdermal ISF
extraction and fluid manipulation. The simple Venturi tube is
designed using the following equation, which originates from
Bernoulli’s equation:
P1 − P2 = ρ
(
v22 − v21
)
/2 = ρv21
(
A21/A
2
2 − 1
)
/2 (1)
where P1 is the input pressure, P2 is the output vacuum, ρ is
density, v1 is the velocity of the input fluid, v2 is the velocity of
the fluid in the vena contracta section, and A1 and A2 are chan-
nel areas of the input section and the vena contracta section,
respectively. By forcing the gas through the convergent and the
vena contracta sections, the gas velocity increases and results in
a pressure drop that is greatest just before the divergent section
toward the outlet. Under the correct conditions, pressures less
than the ambient (vacuum) can be generated, which are used
for ISF extraction and fluid manipulation. The structure of the
vacuum generator in this system was optimized to be suitable
for microfluidics. A dimensioned diagram of the optimized
geometry for this work is shown in Fig. 2. The width and height
of the vena contracta section are both 230 μm, and the ratio
of the width of the input section to that of the vena contracta
section is 37 : 1.
C. Structure Design of the Micro Pneumatic Valve
A micro pneumatic valve is designed to manage the ISF
extraction, collection, and volumetric measurement processes
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Fig. 2. Dimensioned drawing of vacuum generator. Units are shown in mm.
Fig. 3. Structure of pneumatic valve (Unit: mm). A: vacuum generator layer,
B: valve layer, C: flow sensor layer.
under computer control. The pneumatic valve with a simple
structure is easy to control and responds rapidly.
The structure of the pneumatic valve fabricated with poly-
dimethylsiloxane (PDMS) is shown in Fig. 3. When an external
pressure is applied on the surface of the valve membrane, the
membrane will deflect to the flow sensor layer and connect
to the vertical connecting channel. As a result, the connection
between the microfluidic channel on the valve layer and the
vertical connecting channel will be blocked, causing the valve
to close. When the external pressure is restored to atmospheric
pressure, the valve will reopen.
When the circular PDMS membrane of radius a carries a
pressure p that is uniformly distributed over the entire surface
of the valve membrane, the deflection of the membrane at a
distance r from the center of the membrane is determined by
the equation
w =
p(a2 − r2)2
64D
(2)
where the flexural rigidity of the membrane D is determined by
the equation
D =
Eh3
12(1− υ2) (3)
where E is Young’s modulus, h is thickness of the membrane,
and ν is Poisson’s ratio. According to (2) and (3), the pressure
TABLE II
PARAMETERS OF THE VALVE MEMBRANE
Fig. 4. (a) Schematic of the flow sensor with two pairs of electrodes for
a situation corresponding to the time period between t2 and t3. (b) Timing
diagram of the electrodes resistance.
that will cause the pneumatic valve to close is determined by
the equation
p =
64Dw
(a2 − r2)2 =
16
3
· Eh
3w
(1− υ2)(a2 − r2)2 . (4)
Based on the properties of PDMS and the dimensions of
the pneumatic valve, the parameters of the valve membrane
are presented in Table II. Utilizing these parameters and (4),
the pressure needed to close the valve was calculated and
determined to be 62.85 kPa (relative pressure).
D. Structure Design of the Micro Flow Sensor
The viability of this system hinges on the ability to accurately
measure the amount of normal saline solution and ISF in order
to provide essential information for accurate continuous glu-
cose monitoring. Utilizing the conductivity of the electrolytic
fluid (e.g., normal saline, ISF) in our application, a flow sensor
that is simple in operation and readily integrated has been ob-
tained. The flow sensor comprises of electrode pairs located in
a microfluidic channel of a fixed dimension. Each pair of elec-
trodes is separated by a small gap inside the channel such that
the electrolytic fluid flowing through the channel will bridge
the gap, and the resistance between the electrodes will decrease
sharply. During operation of the system, the resistance of each
electrode pair and the timing of any resistance change are mon-
itored. In addition, the duration of the changes in the electrode
pair resistance and the dimensions of the microfluidic chan-
nel are used to calculate the volume of the electrolytic fluid.
The stable vacuum generated from the vacuum generator
uniformly accelerates the electrolytic fluid in the uniform mi-
crofluidic channel in the ISF transdermal extraction, collection,
and volumetric measurement system. The schematic of a flow
sensor with two pairs of electrodes is shown in Fig. 4(a), and
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the corresponding timing diagram of the electrodes’ resistance
is shown in Fig. 4(b). The head of the electrolytic fluid sec-
tion passes Electrodes 1 (E1) at time t1, and its velocity and
acceleration are defined as v1 and a, respectively. When the
fluid section flows through the channel at time t2, t3, and t4,
its velocity is v2 = v1 + a(t2 − t1), v3 = v1 + a(t3 − t1), and
v4 = v1 + a(t4 − t1), respectively.
Therefore, the distance between the two pairs of electrodes
S and the length of the liquid section L can be expressed as
follows:
S = [v1 + v1 + a(t2 − t1)] (t2 − t1)/2
= [v1 + a(t3 − t1) + v1 + a(t4 − t1)] (t4 − t3)/2 (5)
L = [v1 + v1 + a(t3 − t1)] (t3 − t1)/2. (6)
From (5), v1 and a are obtained as follows:
v1 =
S
[
t24 − t23 − t22 − t21 − 2t1(t4 − t3 − t2)
]
(t4 − t3)(t2 − t1)(t4 + t3 − t2 − t1) (7)
a =
2S(−t4 + t3 + t2 − t1)
(t4 − t3)(t2 − t1)(t4 + t3 − t2 − t1) . (8)
Insert v1 and a into (6) and L is obtained
L =
S(t3 − t1)(t4 − t2)(t4 − t3 + t2 − t1)
(t4 − t3)(t2 − t1)(t4 + t3 − t2 − t1) . (9)
The exceptional case for uniformly accelerated motion is
uniform motion. As such, when the duration of the electrolytic
fluid section flowing through the flow sensor is very short,
the uniformly accelerated motion can be simplified to uniform
motion. For uniform motion, the constant velocity is v1 and
the acceleration a equals zero, that is to say t4 − t3 = t2 − t1.
Therefore,
L =
S(t3 − t1)
(t2 − t1) . (10)
Since the geometry of the flow channel is known, the volume
of fluid can then be calculated as follows:
V = LWH (11)
where W and H are the width and height of the channel,
respectively.
According to the volumetric measurement principle of the
flow sensor with two pairs of electrodes, a flow sensor with
four pairs of electrodes is designed in the system to satisfy the
requirements for accurately measuring the ISF volume. In order
to decrease the length of the flow sensor, a curved microfluidic
channel is used instead of the straight microfluidic channel.
III. FABRICATION PROCESS
In order to prove the viability of this concept, the system
was fabricated from five PDMS layers (shown in Fig. 5):
the vacuum generator layer, the valve layer, the flow sensor
layer, the electrodes layer, and the bottom layer. Except for the
electrodes layer, every layer was fabricated using standard SU-8
Fig. 5. Schematic view of the system with five PDMS layers.
micromolding techniques. The electrodes on the surface of
the electrodes layer were fabricated using conductive PDMS
similar to the method utilized by Niu et al. [21]. However, a
laser cut Kapton tape patterning process had been developed
that substituted the micromold fabrication with a photo resist.
A. Processes for Micromolding the PDMS Layers
1) SU-8 100 (MicroChem) was spun on a bare 100-mm sil-
icon wafer. The SU-8 was subsequently lithographically
patterned to form molds of the desired geometry.
2) PDMS (Sylgard 184, Dow Corning) was mixed in a 10 : 1
ratio of PDMS base with the curing agent. After 45 min of
degassing in the vacuum jar, the PDMS was poured onto
SU-8 molds.
3) The PDMS layers cured at 80 ◦C for one hour were peeled
from the molds.
B. Processes for Fabricating the Electrodes Layer
1) Kapton tape adhering to the aluminum plate was cut by
a laser (VersaLASER VLS 3.50), and the electrode parts
were peeled from the aluminum plate.
2) Kapton tape left on the aluminum plate was cleaned in an
ultrasonic bath and moved to a 100-mm glass wafer.
3) Ag microparticles were mixed with PDMS in a 4 : 1
weight ratio to form conductive PDMS.
4) After the conductive PDMS was plastered on the Kapton
tape, the Kapton tape was peeled carefully from the glass
wafer, and the conductive PDMS electrodes were left on
the surface of the glass wafer.
5) The conductive PDMS electrodes were cured at 80 ◦C for
one hour, and the PDMS was poured onto the surface of
the glass wafer.
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Fig. 6. (a) Laser cut Kapton tape adhering to a glass wafer. (b) Conductive
PDMS electrodes on a glass wafer. (c) Photograph of PDMS sheet with
electrodes. (d) and (e) are enlarged views of the highlighted part in (c) taken
from electrode side and PDMS side, respectively.
Fig. 7. Photograph of the system. NSC: Normal Saline Chamber, EC: Extrac-
tion Chamber, CC: Collection Chamber, VG: Vacuum Generator. E1, E2, E3,
and E4 are four pairs of electrodes.
6) The PDMS layer cured at 80◦C for one hour was peeled
from the glass wafer to obtain the electrodes layer.
C. Processes for Integrating the Five PDMS Layers
1) The access ports for the external tubes and the air vent
of the vacuum generator were punched in the vacuum
generator layer.
2) The vertical interconnecting channels between the differ-
ent layers and the chambers were drilled and punched in
the other four layers.
3) The five layers of PDMS were aligned and bonded to-
gether using oxygen plasma (900 mTorr O2, 25 W, 25 s).
D. Fabrication Results
Using the illustrated fabrication process, an ISF transdermal
extraction, collection, and volumetric measurement system was
obtained. Photographs of the electrodes and the completed
system are shown in Figs. 6 and 7, respectively.
IV. RESULTS AND DISCUSSIONS
A complete system test was performed to verify the func-
tionality of the system. The vacuum for ISF extraction and
fluid manipulation, the pressure required to close the pneumatic
valve, and the ISF volume measurement function of the system
were tested.
A. Test Results of the Vacuum Generator
The schematic diagram of the experimental setup for the
vacuum generator output vacuum measurements is shown in
Fig. 8. Schematic diagram of experimental setup for vacuum generator output
vacuum measurements.
Fig. 9. Output vacuum of vacuum generator versus input pressure.
Fig. 8. A N2 gas cylinder provided the external pressure that
was regulated and applied to the vacuum generator through
the pressure inlet. This external pressure was measured us-
ing a pressure sensor (40PC100G2A, Honeywell Sensing and
Control). A vacuum pressure sensor (40PC015V2A, Honeywell
Sensing and Control) was connected to the microfluidic channel
on the left side of the collection chamber. Five nylon tubes (only
one line of connection is shown in Fig. 8) fixed on the top of
the pneumatic valve membrane were connected to five solenoid
valves (M125 AE1 LW 24 VDC, Humphrey). The state of the
pneumatic valve was determined by the pressure on the top of
its membrane. After regulation, the external pressure generated
from the N2 gas cylinder was applied to the solenoid valves.
When the solenoid valve opened, the external pressure was ap-
plied to the pneumatic valve of the system and would cause the
valve to close. Otherwise, the external pressure was obstructed
and the top of pneumatic valve membrane was exposed to the
atmosphere, which allowed the pneumatic valve to remain open
and for fluid to flow through the corresponding microfluidic
channel. A data acquisition interface (NI USB-M6251) was
used to sample and record the input pressure and the output vac-
uum signal of the vacuum generator and to control the solenoid
valve. When the five pneumatic valves were all closed, both of
the vena contracta section of the vacuum generator and the vac-
uum pressure sensor were connected to the collection chamber.
The output vacuum of the vacuum generator was measured by
controlling the valve states and by regulating the input pressure.
As shown in Fig. 9, a vacuum pressure of less than 91 kPa
was achieved when a pressure of 220 kPa was applied. This
level of vacuum is sufficient for ISF extraction and fluid manip-
ulation in our system.
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Fig. 10. Schematic diagram of experimental setup for pneumatic valve close
pressure measurements.
Despite the fact that Venturi tube can provide adequate
vacuum pressure and pumping speed for the application of
transdermal ISF extraction and fluid manipulation, a micro
pressure generator is required to be integrated into the inlet
section of the Venturi tube to complete a micro vacuum genera-
tor for miniaturized system. For this purpose, a micro pressure
generator using a solid chemical propellant to stably produce
N2 is under research in our lab. And it will be integrated into
our next generation system.
B. Test Results of the Pneumatic Valve
To measure the pneumatic valve actuation pressure, regulator
1, which was connected to the inlet of the vacuum generator,
was substituted with an electrical pressure regulator as shown
in Fig. 10. The pressure sensor was used to measure the valve
close pressure, and the vacuum pressure sensor was used to
monitor the output vacuum flowing through the valve. The
output pressure of the electrical pressure regulator fluctuated
slightly around the pressure set point, resulting in a slight fluc-
tuation of the output vacuum of the vacuum generator. There-
fore, the output signal from the vacuum pressure sensor did not
stop fluctuating until the pressure from regulator 2 was great
enough to close the pneumatic valve. In order to overcome this,
the pressure on the surface of the pneumatic valve membrane
was regulated, and the vacuum and the pressure were mea-
sured and recorded when the vacuum output ceased fluctuating.
The pressure required to close each pneumatic valve was
measured by varying valve actuation in a coordinated man-
ner. For example, the pressure required to close valve 5 was
measured when valves 1, 2, and 3 were closed, valve 4 was
open, and the vacuum pressure sensor was connected to the
microfluidic channel on the right of valve 5. The pressures
required to close pneumatic valve 5 under different vacuum
pressures are listed in Table III. As presented in Table III, the
Valve Close Pressure is less than 160 kPa. In addition, the
average of the differences between the Valve Close Pressure and
the Vacuum under Valve Membrane is about 59.5 kPa, which is
close to the calculated result (62.85 kPa).
TABLE III
CLOSE PRESSURES OF PNEUMATIC VALVE 5
Fig. 11. Schematic diagram of experimental setup for ISF volume
measurements.
C. Test Results of the Flow Sensor
The schematic diagram of the experimental setup for the flow
sensor to measure the volume of ISF is shown in Fig. 11. Four
10 MΩ resistors (R1, R2, R3, and R4) and four pairs of elec-
trodes (E1, E2, E3, and E4) were connected in series, respec-
tively. A 1.414 V, 100 Hz AC voltage was applied to these four
series circuits. In Fig. 11, the flow sensor and the experimental
setup are simplified; only two pairs of electrodes and their cor-
responding experimental setups are shown. The voltage change
across the 10 MΩ resistor represented the resistance change
of the corresponding electrode pair. After signal conditioning
(impedance reduction and 60 Hz noise filtering), the voltage
data was inputted into the computer through a data acquisition
interface. The sampling frequency was 1 kHz. Under the man-
agement of the pneumatic valves, a 95-kPa vacuum generated
from the vacuum generator in the system was used for fluid ma-
nipulation during normal saline injection and sample collection
processes. During the injection of normal saline, the voltage on
resistor R4 was detected and used to determine the valve status
in order to control the input volume of normal saline. During
the collection of the sample, the voltage on the four resistors
was measured, and the duration of voltage change was used
to calculate the volume of the sample and the volume of ISF.
In order to test the accuracy of the integrated flow sensor
for ISF volume measurement, a simulated ISF extraction was
performed. Normal saline solutions with a known volume be-
tween 0 and 3 μL were used to simulate the transdermally
extracted ISF and were injected into the extraction chamber
with a microsyringe (701 N 10 μL, Hamilton) before the input
process of 9.70 μL (this defined volume was determined by
the volume of the microfluidic channel between valve 3 and
electrode pair E4 and was measured by a microsyringe to
inject and extract normal saline solution in the microfluidic
channel) of normal saline solution. The defined volume was
then transferred into the extraction chamber, mixed with the
normal saline simulating the ISF, collected from the extraction
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TABLE IV
FLOW SENSOR TEST RESULTS COMPARED TO MICROSYRINGE
Fig. 12. Tested added volume measured by flow sensor versus Added Volume
by microsyringe.
chamber to the collection chamber, and measured using the flow
sensor. Six different volumes from 0 to 3 μL were tested in fixed
increments of 0.5 μL to simulate varied ISF volumes. For each
volume, the simulated ISF volume test was repeated 5 times.
The flow sensor test results of the simulated ISF volume
measurements are presented in Table IV. The tested mean
volume was the average (n = 5) of the sample (mixture of the
normal saline simulating the ISF and the normal saline with
defined input volume) volume measured by the flow sensor.
The tested added volume was calculated as the difference of the
tested mean volume between the sample and the defined input
normal saline. The correlation between the tested added volume
and the added volume measured by the microsyringe is shown
in Fig. 12. As presented in Table IV, the standard deviation
for every sample is less than 0.07 μL, and the absolute error
of the added volume (to simulate the transdermally extracted
ISF volume) measurement is less than 0.17 μL. Specifically,
when the added volume is no more than 1.50 μL, the absolute
error is less than 0.04 μL. The correlation coefficient of the
measurement between the tested added volume and the added
volume measured by the microsyringe is R2 = 0.9992, which
indicates a strong relationship between the volume measured by
the flow sensor and the extracted ISF volume.
D. Results of ISF Extraction Through Pig Skin
Through low-frequency ultrasound pretreated pig skin which
has the same basic structure as human skin, ISF transdermal ex-
traction, collection, and volume measurement were performed
to verify the functionalities of the system.
After sacrificing the pig, the hair on the back and the ab-
domen were shaved with a blade, and the skin was harvested
immediately. Superfluous tissues such as fat and muscle were
removed carefully. Skin, with the exception of flawed pieces
which had visible imperfection such as scratches and abrasion,
Fig. 13. Schematic diagram of the experimental setup for ISF transdermal
extraction through pig skin. SC: Stratum Corneum, FTS: Full-Thickness Skin,
CS: Clamping Structure.
was cut into small pieces (10 cm × 10 cm) and was stored in
a −20 ◦C freezer for up to 4 weeks until the experiments were
performed.
The schematic diagram of the experimental setup for ISF
transdermal extraction through pig skin is shown in Fig. 13.
Before each experiment, the skin was thawed at room tempera-
ture, pretreated by low-frequency ultrasound (SonoPrep, Sontra
Medical), and mounted onto a container which was filled with
normal saline solution with different glucose concentrations
(1000, 1500, and 2000 mg/dL). The “ISF analog” was stirred
continuously throughout the experiment. The system was held
on the top of the skin with the ultrasound treated skin directly
underneath the extraction chamber. A 95-kPa vacuum generated
from the vacuum generator in the system was used for “ISF
analog” transdermal extraction and fluid manipulation. After
the vacuum pressure was connected to the extraction chamber,
the skin underneath the extraction chamber swelled and bulged
into the extraction chamber, thus the extraction chamber was
well sealed with the skin. The duration of ISF transdermal
extraction was set to be 10 min which was chosen for the
final glucose monitoring goal to display and record the glucose
concentration once every 10 min for one day after a single
ultrasound pretreatment. Following the workflow described in
Table I, the transdermally extracted “ISF analog” was at last
collected into the collection chamber. During the collection
procedure, the volume of the extracted “ISF analog” was mea-
sured using the integrated flow sensor. Finally, the glucose
concentration of the sample in the collection chamber was
tested (FreeStyle Freedom, Abbott).
The sample in the collection chamber was the mixture of
the transdermally extracted “ISF analog” and the normal saline
with defined input volume. The glucose concentration of the
“ISF analog” CISF and the defined input volume of the nor-
mal saline VNS were known, and the glucose concentration
of the sample CS was tested. Therefore, the volume of the
transdermally extracted “ISF analog” VISF can be calculated
as: VISF = VNS · CS/(CISF − CS). The “ISF analog” volume
measurement results of the integrated flow sensor were com-
pared with the calculated results.
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TABLE V
TRANSDERMALLY EXTRACTED ISF VOLUME TEST RESULTS
(DEFINED INPUT VOLUME: 8.40 μL.)
Under the management of the pneumatic valves and by
using the 95-kPa vacuum force generated from the vacuum
generator, this system was used to transdermally extract and
collect the “ISF analog” through ultrasound pretreated pig skin
and to measure the volume of the transdermally extracted “ISF
analog.” Two pieces of pig skin were tested in the experiment.
The “ISF analog” volume measurement results of the flow
sensor were compared with the calculated results from the
tested glucose concentrations of the sample. As presented in
Table V, the volumes of “ISF analog” which was transdermally
extracted using a 95-kPa vacuum in 10 min are between 0
and 3.5 μL. This proves the feasibility of using the vacuum
generator, which can achieve a vacuum pressure of less than
91 kPa, for ISF extraction. In addition, the absolute error of the
volume measurements is less than 0.05 μL. The low absolute
error values of the measurement results indicate a high accuracy
of the integrated flow sensor. It proves the feasibility of using
the flow sensor for ISF volume measurement.
As shown in Table V, the transdermally extracted ISF vol-
umes increased gradually with the extraction times for both of
the skin pieces. The possible reason for the volume enhance-
ment is following. In the process of ISF transdermal extrac-
tion, the skin underneath the extraction chamber swelled under
vacuum pressure. On the skin surface, the pores generated in
the ultrasound pretreatment were enlarged. In addition, the in
vitro skin lacks elasticity to return to its original size and shape.
Therefore, the skin permeability increased gradually.
In order to develop a continuous glucose monitoring device
based on the microfluidic system in this paper, there are several
technical issues that require to be solved in the near future.
1) The glucose concentration of the sample in the collection
chamber is lower than the glucose concentration of the ISF
with a dilution factor around 10. A more sensitive glucose
sensor than the common blood glucose sensor is needed. For
this purpose, a high sensitive glucose sensor, which has long
lifetime, based on surface plasmon resonance [22] is being
studied in our group. This sensor will be integrated into the
collection chamber. 2) For the current microfluidic system, the
collection chamber has to be cleaned and dried up before next
measurement. The interior surface of the collection chamber
will be treated to obtain a hydrophobic surface for automatically
expelling the sample from the collection chamber into a waste
reservoir with vacuum pressure. 3) Experiments on human skin
will be performed to find the appropriate parameters, such as the
length of ultrasound pretreatment time and vacuum pressure,
for ISF extraction through human skin and to evaluate the
performance of the continuous glucose monitoring device.
V. CONCLUSION
This paper has demonstrated a microfluidic system for ISF
extraction, collection, and volumetric measurement toward the
application for glucose monitoring. A vacuum pressure of less
than 91 kPa has been achieved from the vacuum generator
in this system. A novel integrated flow sensor that is able to
stably control the defined volume of normal saline injection
and is capable of consistently measuring the volume of the
extracted ISF has been demonstrated. This consistency is shown
by the high correlation coefficient (R2 = 0.9992) between the
tested volume and the volume measured by a microsyringe in
a simulated ISF extraction test. Under the management of the
pneumatic valves and by using the 95-kPa vacuum force gener-
ated from the vacuum generator, this system has been proven to
successfully extract “ISF analog” through ultrasound pretreated
pig skin, manipulate fluid transport in the system, and accu-
rately measure the volume of transdermally extracted ISF. The
absolute error in the volume measurements of the transdermally
extracted “ISF analog” is less than 0.05 μL. Future efforts will
be concentrated on integrating a micro glucose sensor into the
ISF collection chamber in the microfluidic system to form a
complete continuous glucose monitoring device.
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